ADVFN US – Market Content Editor

  • J.M. Smucker shares rise after earnings beat and upgraded annual outlook

    J.M. Smucker shares rise after earnings beat and upgraded annual outlook

    J.M. Smucker (NYSE:SJM) shares gained more than 3% in premarket trading on Wednesday after the packaged foods company delivered stronger-than-expected first-quarter earnings and revenue and raised its full-year profit guidance. The company reported earnings of $3.24 per share, comfortably ahead of the analyst consensus estimate of $2.21. Revenue increased 5% year-over-year to $2.2 billion, exceeding…

  • Abercrombie & Fitch shares soar after earnings beat and upgraded outlook

    Abercrombie & Fitch shares soar after earnings beat and upgraded outlook

    Abercrombie & Fitch Co. (NYSE:ANF) shares jumped more than 11% in premarket trading after the apparel retailer delivered second-quarter earnings and revenue above Wall Street forecasts and raised its full-year guidance. Adjusted earnings reached $4.17 per share, exceeding the analyst consensus of $1.98 by $2.19. Revenue increased 5% year-over-year to $1.3 billion, ahead of expectations…

  • Summit Therapeutics shares rise after partner reports positive Phase III cancer trial results

    Summit Therapeutics shares rise after partner reports positive Phase III cancer trial results

    Summit Therapeutics Inc. (NASDAQ:SMMT) shares climbed 7.75% on Wednesday after partner Akeso Inc. reported positive topline results from a Phase III study evaluating ivonescimab in advanced biliary tract cancer. Akeso said the HARMONi-GI1 trial achieved its primary endpoint, with ivonescimab combined with chemotherapy demonstrating statistically significant superiority in overall survival compared with durvalumab plus chemotherapy…

  • Dycom Industries beats Q2 forecasts as digital infrastructure demand accelerates

    Dycom Industries beats Q2 forecasts as digital infrastructure demand accelerates

    Dycom Industries Inc. (NYSE:DY) reported second-quarter results above Wall Street expectations on Wednesday, supported by strong demand for digital infrastructure deployment and continued expansion across its core markets. Shares of the specialist contractor gained 1.76% in premarket trading following the announcement. Adjusted earnings reached $5.29 per share, comfortably exceeding the consensus estimate of $4.70. Revenue…

  • Kohl’s shares fall despite earnings beat and stronger full-year guidance

    Kohl’s shares fall despite earnings beat and stronger full-year guidance

    Kohl’s Corporation (NYSE:KSS) shares fell more than 8% in premarket trading on Wednesday, reversing an earlier gain even after the retailer delivered second-quarter earnings well above expectations and raised its full-year profit forecast. Adjusted earnings reached $1.28 per share, beating the analyst consensus of $0.57 by $0.71. Revenue was less impressive, however, coming in at…

  • JinkoSolar shares fall after second-quarter earnings and revenue miss forecasts

    JinkoSolar shares fall after second-quarter earnings and revenue miss forecasts

    JinkoSolar Holding Co., Ltd. (NYSE:JKS) shares dropped 4.63% in premarket trading after the solar module manufacturer reported second-quarter results that fell short of analysts’ expectations for both earnings and revenue. The company recorded an adjusted loss of RMB13.19 ($1.94) per ADS, considerably wider than the consensus forecast for a loss of RMB6.09. Revenue declined 31.3%…

  • Bath & Body Works lifts full-year earnings outlook after Q2 profit beats forecasts

    Bath & Body Works lifts full-year earnings outlook after Q2 profit beats forecasts

    Bath & Body Works (NYSE:BBWI) reported second-quarter earnings significantly above Wall Street expectations and raised its full-year profit guidance, although a weaker-than-expected third-quarter earnings forecast highlighted continued pressure on the underlying business. The company posted second-quarter earnings of $0.62 per share, comfortably exceeding the analyst consensus estimate of $0.24. Revenue reached $1.5 billion, broadly matching…

  • Biohaven shares climb 7% after signing major SK Biopharmaceuticals licensing deal

    Biohaven shares climb 7% after signing major SK Biopharmaceuticals licensing deal

    Biohaven Ltd. (NYSE:BHVN) shares gained 7% on Wednesday after the biotechnology company announced a strategic global licensing agreement with SK Biopharmaceuticals covering its Kv7 ion channel platform and epilepsy candidate opakalim. The transaction could deliver up to $795 million in upfront and milestone payments associated with the Kv7 platform, while also providing Biohaven with ongoing…

  • Target Hospitality shares surge 10% after securing $250 million data centre contract

    Target Hospitality shares surge 10% after securing $250 million data centre contract

    Target Hospitality Corp. (NASDAQ:TH) shares climbed 10% on Wednesday after the company secured a new multi-year contract expected to generate approximately $250 million in revenue from a major hyperscaler data centre project. Under the agreement, Target Hospitality will provide comprehensive facility and hospitality services for a data centre development in the Pecos region of West…

  • Movado Group shares rise 3% after second-quarter earnings and revenue beat forecasts

    Movado Group shares rise 3% after second-quarter earnings and revenue beat forecasts

    Movado Group, Inc. (NYSE:MOV) shares gained 3% on Wednesday after the watchmaker reported fiscal second-quarter 2027 results that comfortably exceeded analysts’ expectations for both earnings and revenue. Adjusted earnings came in at $0.54 per share, well ahead of the consensus estimate of $0.35. Revenue increased 4.9% year-over-year to $169.8 million from $161.8 million, also beating…